Pieris AG

About:

Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and so on.

Website: http://www.pieris-ag.com

Top Investors: Forbion Capital Partners, Gilde Healthcare, ABN AMRO Fund, TransConnect, Gilde IT Fund

Description:

Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and other medical conditions with unmet medical needs. The company applies its proprietary Anticalin® technology to the drug development processes. Pieris Pharmaceuticals was founded in 2001 and is based in Freising, Bayern.

Total Funding Amount:

$18.3M

Headquarters Location:

Hallbergmoos, Bayern, Germany

Founded Date:

2001-01-01

Contact Email:

info(AT)pieris-ag.com

Founders:

Claus Schalper

Number of Employees:

101-250

Last Funding Date:

2006-11-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai